Inborn errors of metabolism
MONDO:0019052An inherited disorder resulting from an enzyme defect in biochemical and metabolic pathways affecting proteins, fats, carbohydrates metabolism or organelle function.
Also known as: congenital metabolic disorder, congenital metabolism disorder, hereditary metabolic disease, inborn disorders of metabolism, inborn error of metabolism, inborn errors of metabolism, inborn metabolic disorder, inherited disorder of metabolism
2231 clinical trials for this condition and its sub-types, 48 tagged with Inborn errors of metabolism itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Inborn errors of metabolism
-
Inherited lipid metabolism disorder 201 trials · 644 incl. sub-types
29 sub-types
- Lysosomal lipid storage disorder 2 trials · 192 incl. sub-types Sub-types →
- Familial hyperlipidemia 8 trials · 130 incl. sub-types Sub-types →
- Syndromic dyslipidemia 0 trials · 73 incl. sub-types Sub-types →
- Sterol metabolism disorder 0 trials · 60 incl. sub-types Sub-types →
- Steroid inherited metabolic disorder 0 trials · 39 incl. sub-types Sub-types →
- Inherited fatty acid metabolism disorder 7 trials · 21 incl. sub-types Sub-types →
- Disorder of phospholipids, sphingolipids and fatty acids biosynthesis 0 trials · 15 incl. sub-types Sub-types →
- Hypolipoproteinemia 2 trials · 7 incl. sub-types Sub-types →
- Glucocorticoid resistance 3 trials
- Mitochondrial trifunctional protein deficiency 3 trials Sub-types →
- Vitamin D hydroxylation-deficient rickets, type 1B 3 trials
- 46,XY disorder of sex development due to 5-alpha-reductase 2 deficiency 2 trials
- CYP7B1-related disorder of oxysterol accumulation 0 trials · 2 incl. sub-types Sub-types →
- Disorder of plasmalogens biosynthesis 0 trials · 2 incl. sub-types Sub-types →
- Disorder of sphingolipid biosynthesis 1 trial
- Inborn disorder of ketolysis 0 trials · 1 incl. sub-types Sub-types →
- Corticosterone methyloxidase type 1 deficiency 0 trials
- Cortisone reductase deficiency 0 trials Sub-types →
- Developmental and epileptic encephalopathy, 55 0 trials
- Developmental and epileptic encephalopathy, 77 0 trials
- Developmental and epileptic encephalopathy, 80 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 15 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 16 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 17 0 trials
- Glycosylphosphatidylinositol biosynthesis defect 18 0 trials
- Inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation 0 trials Sub-types →
- Lipoid proteinosis 0 trials
- Neurodevelopmental disorder with hypotonia and cerebellar atrophy, with or without seizures 0 trials
- Pancreatic triacylglycerol lipase deficiency 0 trials Sub-types →
-
Inborn carbohydrate metabolic disorder 3 trials · 370 incl. sub-types
18 sub-types
- Disorder of carbohydrate transmembrane transport and absorption 0 trials · 162 incl. sub-types Sub-types →
- Disorder of glycogen metabolism 15 trials · 69 incl. sub-types Sub-types →
- Mucopolysaccharidosis 14 trials · 62 incl. sub-types Sub-types →
- Disorder of glycolysis 1 trial · 27 incl. sub-types Sub-types →
- Primary hyperoxaluria 13 trials · 17 incl. sub-types Sub-types →
- Hyperinsulinemic hypoglycemia 2 trials · 14 incl. sub-types Sub-types →
- Oligosaccharidosis 0 trials · 11 incl. sub-types Sub-types →
- Lactose intolerance 9 trials · 10 incl. sub-types Sub-types →
- G6PD deficiency 6 trials Sub-types →
- GLUT1 deficiency syndrome 4 trials · 5 incl. sub-types Sub-types →
- Disorder of galactose metabolism 0 trials · 5 incl. sub-types Sub-types →
- Disorder of galactose and fructose metabolism 0 trials · 4 incl. sub-types Sub-types →
- Pyruvate dehydrogenase deficiency 2 trials · 4 incl. sub-types Sub-types →
- Multiple carboxylase deficiency 0 trials · 3 incl. sub-types Sub-types →
- Congenital disorder of deglycosylation 1 2 trials
- Disorder of fructose metabolism 0 trials · 1 incl. sub-types Sub-types →
- Disorder of gluconeogenesis 0 trials · 1 incl. sub-types Sub-types →
- Disorders of pentose/polyol metabolism 0 trials · 1 incl. sub-types Sub-types →
-
Abdominal obesity-metabolic syndrome 302 trials · 359 incl. sub-types
5 sub-types
- Metabolic syndrome X 340 trials
- LIPE-related familial partial lipodystrophy 0 trials
- Abdominal obesity-metabolic syndrome 3 0 trials
- Abdominal obesity-metabolic syndrome 4 0 trials
- Abdominal obesity-metabolic syndrome quantitative trait locus 2 0 trials
-
Lysosomal storage disease 38 trials · 303 incl. sub-types
11 sub-types
- Lysosomal lipid storage disorder 2 trials · 192 incl. sub-types Sub-types →
- Mucopolysaccharidosis 14 trials · 62 incl. sub-types Sub-types →
- Lysosomal glycogen storage disease 0 trials · 45 incl. sub-types Sub-types →
- Inborn disorder of lysosomal amino acid transport 0 trials · 15 incl. sub-types Sub-types →
- Glycoproteinosis 0 trials · 14 incl. sub-types Sub-types →
- Late infantile neuronal ceroid lipofuscinosis 1 trial · 5 incl. sub-types Sub-types →
- Disorder of sialic acid metabolism 0 trials · 1 incl. sub-types Sub-types →
- Glycoprotein storage disease 0 trials
- Hereditary spastic paraplegia 48 0 trials
- Lysosomal acid phosphatase deficiency 0 trials
- Pycnodysostosis 0 trials
-
Inborn disorder of energy metabolism 2 trials · 235 incl. sub-types
6 sub-types
- Inborn mitochondrial metabolism disorder 59 trials · 127 incl. sub-types Sub-types →
- Disorder of glycogen metabolism 15 trials · 69 incl. sub-types Sub-types →
- Pyruvate metabolism disorder 0 trials · 31 incl. sub-types Sub-types →
- Disorder of fatty acid and ketone body metabolism 3 trials · 19 incl. sub-types Sub-types →
- Cerebral creatine deficiency syndrome 0 trials · 6 incl. sub-types Sub-types →
- Tricarboxylic acid cycle disorder 0 trials · 2 incl. sub-types Sub-types →
-
Inborn disorder of amino acid and other organic acid metabolism 0 trials · 225 incl. sub-types
13 sub-types
- Inborn disorder of amino acid metabolism 6 trials · 159 incl. sub-types Sub-types →
- Pyruvate metabolism disorder 0 trials · 31 incl. sub-types Sub-types →
- Inherited fatty acid metabolism disorder 7 trials · 21 incl. sub-types Sub-types →
- Disorder of melanin metabolism 0 trials · 15 incl. sub-types Sub-types →
- Inborn disorder of bile acid synthesis 2 trials · 12 incl. sub-types Sub-types →
- Inborn disorder of methionine cycle and sulfur amino acid metabolism 0 trials · 11 incl. sub-types Sub-types →
- Inborn disorder of ornithine or proline metabolism 0 trials · 4 incl. sub-types Sub-types →
- Inborn error of biotin metabolism 0 trials · 3 incl. sub-types Sub-types →
- Inborn disorder of serine family metabolism 0 trials · 1 incl. sub-types Sub-types →
- Inborn disorder of the gamma-glutamyl cycle 0 trials · 1 incl. sub-types Sub-types →
- Disorder of beta and omega amino acid metabolism 0 trials Sub-types →
- Disorder of glutamine metabolism 0 trials Sub-types →
- Inborn disorder of lysine and hydroxylysine metabolism 0 trials Sub-types →
-
Waldenstrom macroglobulinemia 136 trials
2 sub-types
- Macroglobulinemia, Waldenstrom, 1 2 trials
- Macroglobulinemia, Waldenstrom, 2 0 trials
-
DNA repair disease 13 trials · 105 incl. sub-types
16 sub-types
- Fanconi anemia 29 trials · 42 incl. sub-types Sub-types →
- Mismatch repair cancer syndrome 5 trials · 36 incl. sub-types Sub-types →
- Cockayne syndrome 6 trials Sub-types →
- Xeroderma pigmentosum 4 trials · 6 incl. sub-types Sub-types →
- Severe combined immunodeficiency due to DCLRE1C deficiency 3 trials
- Karyomegalic interstitial nephritis 2 trials
- Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy 0 trials · 2 incl. sub-types Sub-types →
- COFS syndrome 1 trial Sub-types →
- Nijmegen breakage syndrome 1 trial
- Nijmegen breakage syndrome-like disorder 0 trials
- UV-sensitive syndrome 0 trials Sub-types →
- Ataxia and polyneuropathy, adult-onset 0 trials
- Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia 0 trials
- Ataxia-telangiectasia-like disorder 1 0 trials
- Ataxia-telangiectasia-like disorder 2 0 trials
- Photosensitive trichothiodystrophy 0 trials Sub-types →
-
Hereditary amyloidosis 19 trials · 79 incl. sub-types
9 sub-types
- Familial amyloid neuropathy 52 trials · 54 incl. sub-types Sub-types →
- Cerebral amyloid angiopathy 16 trials · 17 incl. sub-types Sub-types →
- APP-related brain and vascular amyloidosis 0 trials · 5 incl. sub-types Sub-types →
- Familial primary localized cutaneous amyloidosis 1 trial Sub-types →
- Finnish type amyloidosis 0 trials
- ITM2B amyloidosis 0 trials Sub-types →
- Familial visceral amyloidosis 0 trials Sub-types →
- Pulmonary amyloidosis 0 trials
- Variant ABeta2M amyloidosis 0 trials
-
Inborn disorder of porphyrin metabolism 0 trials · 63 incl. sub-types
4 sub-types
- Inborn disorder of bilirubin metabolism 0 trials · 39 incl. sub-types Sub-types →
- Inherited porphyria 0 trials · 24 incl. sub-types Sub-types →
- X-linked sideroblastic anemia 1 0 trials
- Heme oxygenase 1 deficiency 0 trials
-
Mucopolysaccharidosis or mucopolysaccharidosis-like disorder 0 trials · 62 incl. sub-types
2 sub-types
- Mucopolysaccharidosis 14 trials · 62 incl. sub-types Sub-types →
- Mucopolysaccharidosis-plus syndrome 0 trials
-
Inborn metal metabolism disorder 1 trial · 60 incl. sub-types
9 sub-types
- Wilson disease 31 trials
- Pseudohypoparathyroidism 8 trials · 9 incl. sub-types Sub-types →
- Hereditary hemochromatosis 8 trials Sub-types →
- Menkes disease 5 trials
- Familial primary hypomagnesemia 5 trials Sub-types →
- Acrodermatitis enteropathica 2 trials
- Atransferrinemia 1 trial
- Familial periodic paralysis 0 trials · 1 incl. sub-types Sub-types →
- Sulfite oxidase deficiency due to molybdenum cofactor deficiency 0 trials · 1 incl. sub-types Sub-types →
-
Disorder of metabolite absorption and transport 0 trials · 59 incl. sub-types
3 sub-types
- Disorder of mineral absorption and transport 0 trials · 50 incl. sub-types Sub-types →
- Disorder of vitamin and non-protein cofactor absorption and transport 0 trials · 10 incl. sub-types Sub-types →
- Maternal riboflavin deficiency 0 trials
-
Inborn disorder of purine or pyrimidine metabolism 1 trial · 50 incl. sub-types
4 sub-types
- Disorder of glycolysis 1 trial · 27 incl. sub-types Sub-types →
- Inborn disorder of purine metabolism 0 trials · 14 incl. sub-types Sub-types →
- Inborn disorder of pyrimidine metabolism 0 trials · 11 incl. sub-types Sub-types →
- Phosphoribosylpyrophosphate synthetase deficiency 0 trials
-
Plasma protein metabolism disease 0 trials · 47 incl. sub-types
3 sub-types
- Alpha 1-antitrypsin deficiency 44 trials
- Monoclonal paraproteinemia disease 2 trials
- Polyclonal hypergammaglobulinemia 1 trial
-
Peroxisomal disease 2 trials · 38 incl. sub-types
4 sub-types
- Peroxisomal single enzyme/protein defect 0 trials · 35 incl. sub-types Sub-types →
- Peroxisome biogenesis disorder 4 trials · 8 incl. sub-types Sub-types →
- CADDS 0 trials
- Disorder of defective peroxisomal and mitochondrial fission 0 trials Sub-types →
-
Congenital disorder of glycosylation 7 trials · 36 incl. sub-types
25 sub-types
- Disorder of protein O-glycosylation 0 trials · 13 incl. sub-types Sub-types →
- Disorder of multiple glycosylation 0 trials · 9 incl. sub-types Sub-types →
- Congenital disorder of glycosylation type I 0 trials · 7 incl. sub-types Sub-types →
- Disorder of protein N-glycosylation 0 trials · 7 incl. sub-types Sub-types →
- Congenital disorder of glycosylation type II 0 trials · 3 incl. sub-types Sub-types →
- Autosomal recessive limb-girdle muscular dystrophy type 2P 1 trial
- A4GALT-congenital disorder of glycosylation 0 trials
- ALG10-congenital disorder of glycosylation 0 trials
- ALG14-congenital disorder of glycosylation 0 trials Sub-types →
- B3GALT6-congenital disorder of glycosylation 0 trials Sub-types →
- Ehlers-Danlos syndrome, musculocontractural type 0 trials Sub-types →
- FAM20B-congenital disorder of glycosylation 0 trials
- Larsen-like syndrome, B3GAT3 type 0 trials
- SLC10A7-congenital disorder of glycosylation 0 trials
- XYLT1-congenital disorder of glycosylation 0 trials
- Congenital disorder of glycosylation syndrome type 4 0 trials
- Congenital disorder of glycosylation with defective fucosylation 0 trials Sub-types →
- Congenital disorder of glycosylation, type 1DD 0 trials
- Congenital disorder of glycosylation, type Ibb 0 trials
- Congenital disorder of glycosylation, type Iw, autosomal dominant 0 trials
- Congenital muscular dystrophy with intellectual disability 0 trials
- Inborn disorder of glycosphingolipid and glycosylphosphatidylinositol anchor glycosylation 0 trials Sub-types →
- Progressive myoclonic epilepsy type 3 0 trials
- Seizures-scoliosis-macrocephaly syndrome 0 trials
- Temtamy preaxial brachydactyly syndrome 0 trials
-
Monogenic diabetes 9 trials · 24 incl. sub-types
2 sub-types
- Maturity-onset diabetes of the young 8 trials · 13 incl. sub-types Sub-types →
- Neonatal diabetes mellitus 3 trials · 6 incl. sub-types Sub-types →
-
Glycoprotein metabolism disease 1 trial · 23 incl. sub-types
3 sub-types
- Disorder of protein O-glycosylation 0 trials · 13 incl. sub-types Sub-types →
- Disorder of protein N-glycosylation 0 trials · 7 incl. sub-types Sub-types →
- Congenital disorder of deglycosylation 1 2 trials
-
Hereditary lipodystrophy 2 trials · 17 incl. sub-types
11 sub-types
- Familial partial lipodystrophy 13 trials · 14 incl. sub-types Sub-types →
- Congenital generalized lipodystrophy 2 trials · 3 incl. sub-types Sub-types →
- Berardinelli-Seip congenital lipodystrophy 0 trials · 1 incl. sub-types Sub-types →
- Keppen-Lubinsky syndrome 0 trials
- SHORT syndrome 0 trials
- Wiedemann-Rautenstrauch syndrome 0 trials
- Lipoatrophy with diabetes, leukomelanodermic papules, liver steatosis, and hypertrophic cardiomyopathy 0 trials
- Lipodystrophy due to peptidic growth factors deficiency 0 trials
- Lipodystrophy-intellectual disability-deafness syndrome 0 trials
- Mandibuloacral dysplasia 0 trials Sub-types →
- Severe neurodegenerative syndrome with lipodystrophy 0 trials
-
Familial intrahepatic cholestasis 1 trial · 17 incl. sub-types
4 sub-types
- Progressive familial intrahepatic cholestasis 16 trials · 17 incl. sub-types Sub-types →
- Benign recurrent intrahepatic cholestasis 2 trials · 5 incl. sub-types Sub-types →
- Cholestasis, intrahepatic, of pregnancy, 1 0 trials
- Cholestasis, intrahepatic, of pregnancy, 3 0 trials
-
Disorder of lysosomal-related organelles 0 trials · 17 incl. sub-types
5 sub-types
-
Hypophosphatasia 13 trials
8 sub-types
- ALPL-related autosomal dominant hypophosphatasia 0 trials Sub-types →
- ALPL-related autosomal recessive hypophosphatasia 0 trials Sub-types →
- Adult hypophosphatasia 0 trials
- Childhood hypophosphatasia 0 trials
- Infantile hypophosphatasia 0 trials
- Moderate hypophosphatasia 0 trials
- Odontohypophosphatasia 0 trials
- Prenatal benign hypophosphatasia 0 trials
-
Familial hypoparathyroidism 0 trials · 10 incl. sub-types
3 sub-types
- Autosomal dominant hypocalcemia 9 trials · 10 incl. sub-types Sub-types →
- Hypoparathyroidism, familial isolated 1 0 trials Sub-types →
- Hypoparathyroidism, familial isolated, 2 0 trials
-
Inborn disorder of biogenic amine metabolism and transport 0 trials · 10 incl. sub-types
3 sub-types
- Inborn disorder of neurotransmitter metabolism and transport 0 trials · 4 incl. sub-types Sub-types →
- Inborn disorder of pyridoxine metabolism 0 trials · 4 incl. sub-types Sub-types →
- Metabolic disease involving other neurotransmitter deficiency 0 trials · 3 incl. sub-types Sub-types →
-
Neurodegeneration with brain iron accumulation 1 trial · 8 incl. sub-types
14 sub-types
- Neurodegeneration with brain iron accumulation 5 4 trials
- Pantothenate kinase-associated neurodegeneration 4 trials Sub-types →
- PLA2G6-associated neurodegeneration 1 trial Sub-types →
- Kufor-Rakeb syndrome 0 trials Sub-types →
- Woodhouse-Sakati syndrome 0 trials
- Aceruloplasminemia 0 trials
- Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome 0 trials
- Fatty acid hydroxylase-associated neurodegeneration 0 trials
- Neurodegeneration with brain iron accumulation 4 0 trials
- Neurodegeneration with brain iron accumulation 6 0 trials
- Neurodegeneration with brain iron accumulation 7 0 trials
- Neurodegeneration with brain iron accumulation 8 0 trials
- Neurodegeneration with brain iron accumulation 9 0 trials
- Neuroferritinopathy 0 trials
-
Inherited thyroid metabolism disease 0 trials · 8 incl. sub-types
2 sub-types
- Familial thyroid dyshormonogenesis 1 trial · 4 incl. sub-types Sub-types →
- Thyroid hormone resistance syndrome 3 trials · 4 incl. sub-types Sub-types →
-
Inborn vitamin metabolic disorder 0 trials · 7 incl. sub-types
5 sub-types
- Disorders of vitamin D metabolism 0 trials · 3 incl. sub-types Sub-types →
- Inborn disorder of cobalamin metabolism and transport 1 trial · 3 incl. sub-types Sub-types →
- Cerebral folate deficiency 1 trial
- Familial isolated deficiency of vitamin E 1 trial
- Neurodegenerative syndrome due to cerebral folate transport deficiency 1 trial
-
Inborn aminoacylase deficiency 0 trials · 6 incl. sub-types
2 sub-types
- Canavan disease 6 trials Sub-types →
- Aminoacylase 1 deficiency 0 trials
-
Disorder of peptide and amine metabolism 0 trials · 4 incl. sub-types
4 sub-types
- Disorder of methylamine metabolism 0 trials · 2 incl. sub-types Sub-types →
- Disorder of polyamine metabolism 0 trials · 1 incl. sub-types Sub-types →
- Inherited glutathione metabolism disease 0 trials · 1 incl. sub-types Sub-types →
- Inborn disorder of peptide metabolism 0 trials Sub-types →
-
Diastrophic dysplasia 2 trials
-
Hypercalcemia, infantile 2 trials
2 sub-types
- Hypercalcemia, infantile, 1 0 trials
- Hypercalcemia, infantile, 2 0 trials
-
Hypoalphalipoproteinemia, primary, 1 2 trials
-
Congenital disorder of deglycosylation 0 trials · 2 incl. sub-types
2 sub-types
-
Fish eye disease 1 trial
-
2-hydroxyglutaric aciduria 0 trials · 1 incl. sub-types
3 sub-types
- D,L-2-hydroxyglutaric aciduria 1 trial
- D-2-hydroxyglutaric aciduria 0 trials Sub-types →
- L-2-hydroxyglutaric aciduria 0 trials
-
Familial hypocalciuric hypercalcemia 0 trials · 1 incl. sub-types
3 sub-types
-
Hereditary recurrent myoglobinuria 0 trials · 1 incl. sub-types
2 sub-types
-
Thiopurine metabolic disease 0 trials · 1 incl. sub-types
1 sub-type
-
4-hydroxyphenylacetic aciduria 0 trials
-
5-nucleotidase syndrome 0 trials
-
APO A-i deficiency 0 trials
-
3 sub-types
-
Lane Hamilton syndrome 0 trials
-
NAD(P)HX dehydratase deficiency 0 trials
-
3 sub-types
-
Achondrogenesis type IB 0 trials
-
Apolipoprotein c-III deficiency 0 trials
-
Aromatase excess syndrome 0 trials
-
Atelosteogenesis type II 0 trials
-
Autosomal dominant myoglobinuria 0 trials
-
Chondrocalcinosis 2 0 trials
-
Defective apolipoprotein b-100 0 trials
-
Ferro-cerebro-cutaneous syndrome 0 trials
-
Gluthathione peroxidase deficiency 0 trials
-
Hypercholesterolemia, familial, 4 0 trials
-
Hypermanganesemia with dystonia 0 trials
2 sub-types
-
Hypertriglyceridemia 1 0 trials
-
Hypertriglyceridemia 2 0 trials
-
Hypoalphalipoproteinemia, primary, 2 0 trials
1 sub-type
-
2 sub-types
-
Inborn glycerol kinase deficiency 0 trials
3 sub-types
-
Inherited threoninemia 0 trials
-
Multiple epiphyseal dysplasia type 4 0 trials
-
Striatonigral degeneration 0 trials
3 sub-types
-
Uridine-cytidineuria 0 trials
-
Weinstein kliman scully syndrome 0 trials
Most studied deeper sub-types
-
Experimental cell shot aims to boost brain repair in kids with rare metabolic diseases
Disease control Recruiting nowThis early-stage trial tests whether adding special cells (DUOC-01) into the spinal fluid is safe for children with inherited metabolic diseases that damage the brain. Participants are ages 1 week to 21 years and are already receiving a standard umbilical cord blood transplant. T…
Phase 1 • Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New hope for kids: drug may prevent transplant complications
Disease control Recruiting nowThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children and young adults (ages 1-26) with non-cancerous blood disorders who are getting a bone marrow transplant. GVHD is a serious complication where donor cells…
Phase 2 • Sponsor: Sung Won Choi • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Gene therapy trial offers hope for babies with rare, deadly metabolic disease
Disease control Recruiting nowThis study tests a one-time gene therapy called ECUR-506 in baby boys under 9 months old with a severe form of OTC deficiency, a genetic disorder that prevents the body from breaking down ammonia. The goal is to see if the treatment is safe and can reduce dangerous ammonia levels…
Phase 3 • Sponsor: iECURE, Inc. • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Cord blood transplants made more accessible for thousands with blood cancers
Disease control Recruiting nowThis study provides unlicensed cord blood units for transplant to children and adults with blood cancers, immune disorders, and other serious diseases. The goal is to see how well patients recover their white blood cells after the transplant. By making more cord blood units avail…
Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Half-Matched stem cell transplant offers hope for children with rare immune and metabolic diseases
Disease control Recruiting nowThis study tests a new type of stem cell transplant for children with primary immune deficiencies or inherited metabolic disorders. The transplant uses stem cells from a half-matched family donor, which are specially processed to remove certain immune cells. The goal is to see if…
Phase 2 • Sponsor: Johns Hopkins All Children's Hospital • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New immune cell boost may shield kids from Post-Transplant infections
Disease control Recruiting nowThis study tests whether adding memory immune cells (CD45RO) to a stem cell transplant can help children fight off dangerous viral and fungal infections after the procedure. The transplant uses donor stem cells that have been stripped of certain cells to prevent graft-versus-host…
Phase 1/2 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Gene-Editing shot aims to halt rare nerve disease in phase 3 trial
Disease control Recruiting nowThis phase 3 trial tests a single dose of NTLA-2001, a gene-editing therapy, in 60 adults with hereditary transthyretin amyloidosis with polyneuropathy (ATTRv-PN), a rare genetic disease that damages nerves. Participants are randomly assigned to receive either the active treatmen…
Phase 3 • Sponsor: Intellia Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New mRNA treatment for rare metabolic disease moves to Long-Term safety check
Disease control Recruiting nowThis study looks at the long-term safety of an experimental medicine called mRNA-3927 for people with propionic acidemia, a rare genetic disorder that prevents the body from breaking down certain proteins and fats. About 50 participants who were in an earlier study will continue …
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Cord blood transplants offer hope for kids without a donor match
Disease control Recruiting nowThis study tests a cord blood transplant in children and young adults (up to age 21) with life-threatening blood cancers or non-cancer blood disorders who do not have a matched family donor. The goal is to see if this approach lowers the risk of death from treatment one year afte…
Phase 2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New stem cell transplant option for patients without a perfect donor match
Disease control Recruiting nowThis expanded access program offers a stem cell transplant using donor cells that have been specially processed to remove certain immune cells, reducing the risk of graft-versus-host disease. It is for patients with serious blood disorders, immune deficiencies, or metabolic disea…
Early phase 1 • Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
MRNA therapy takes on rare metabolic disease
Disease control Recruiting nowThis study tests an experimental mRNA therapy called mRNA-3927 for propionic acidemia, a rare genetic disorder that causes dangerous metabolic crises. The trial involves about 77 participants of all ages, starting with older children and adults. Researchers will check safety, fin…
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Milder chemo before stem cell transplant shows promise for rare blood disorders
Disease control Recruiting nowThis study tracks 50 children and adults with non-malignant disorders like immune deficiencies and anemias who receive a stem cell transplant after a reduced-intensity chemotherapy regimen. The goal is to see if this approach improves survival and reduces severe graft-versus-host…
Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New mRNA therapy aims to control rare metabolic disease Long-Term
Disease control Recruiting nowThis study is testing the long-term safety of an mRNA therapy called mRNA-3705 in people with methylmalonic acidemia (MMA), a rare genetic disorder that prevents the body from breaking down certain proteins and fats. Participants have already been in earlier studies of this drug.…
Phase 1/2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Milder transplant method aims to help young patients with rare blood diseases
Disease control Recruiting nowThis study is testing a less intense chemotherapy and radiation regimen before a stem cell transplant for children and young adults up to age 55 with non-cancerous blood disorders like immune deficiencies, anemias, and metabolic diseases. The goal is to see if this gentler prepar…
Phase 2 • Sponsor: Paul Szabolcs • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Half-Matched stem cells give bone marrow a jump start for High-Risk patients
Disease control Expanded accessThis program offers extra stem cells from a half-matched family donor to patients who are getting a cord blood transplant for serious blood cancers or immune disorders. The goal is to help the bone marrow recover more quickly while the cord blood cells take over permanently. It i…
Sponsor: Joanne Kurtzberg, MD • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
A cartoon-style program may help children with rare diseases understand their condition and boost mental health
Symptom relief Recruiting nowThis trial tests a short, child-friendly psychoeducation program called Education & Care in RARE for children and teens aged 5–20 with any rare disease. The program uses simple, resource-oriented materials to teach kids about their condition and build coping skills. Researchers w…
Sponsor: Medical University of Vienna • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Rare disease study seeks clues for future treatments
Knowledge-focused Recruiting nowThis study tracks the natural course of fucosidosis, a rare genetic disorder, in up to 57 people. It collects medical history and ongoing health data without giving any experimental treatment. The goal is to better understand the disease and help design future therapies.
Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Knowledge-focused
Last updated Sep 19, 2026 00:00 UTC
-
NIH launches major study to unravel genetic metabolic mysteries
Knowledge-focused Recruiting nowThis study aims to better understand and treat people with certain inherited metabolic or genetic disorders. Researchers will use standard medical tests like blood work and imaging to diagnose and care for participants, who may also join other related studies. The goal is to expa…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 18, 2026 00:00 UTC
-
Millions of unpaid caregivers: study tracks hidden health toll
Knowledge-focused Recruiting nowThis study follows 2,800 unpaid caregivers of people with chronic conditions like diabetes or inherited disorders. Researchers will survey and interview caregivers over up to 5 years to track changes in their health, stress, and social support. The goal is to understand how careg…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 17, 2026 00:00 UTC
-
Scientists launch deep dive into rare metabolic disease MMA
Knowledge-focused Recruiting nowThis study aims to learn more about methylmalonic acidemia (MMA) and related disorders by observing people with these conditions over time. Researchers will track complications, perform tests like blood draws and MRIs, and look for new genetic causes. The goal is to better unders…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 12, 2026 00:00 UTC
-
Scientists launch Largest-Ever study to unravel rare metabolic disease
Knowledge-focused Recruiting nowThis study follows people with propionic acidemia (PA), a rare metabolic disorder, to track how the disease affects the body over time. Researchers will collect medical history, blood, urine, and other samples, and perform imaging and heart tests during annual hospital visits. Th…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
NIH launches study to unlock secrets of rare 'Black Urine' disease
Knowledge-focused Recruiting nowThis study aims to learn more about alkaptonuria, a rare genetic disease that causes a pigment to build up in bones and tissues, leading to arthritis and other problems. Researchers will evaluate 300 patients over several years using advanced medical tests. The goal is to better …
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Sep 03, 2026 00:00 UTC
-
Can a single gene therapy dose keep working for 14 years?
Knowledge-focused Recruiting nowThis study follows people who received an investigational gene therapy in an earlier iECURE trial for a urea cycle disorder, a condition that can cause dangerous ammonia buildup. Researchers will track safety, side effects, and whether the therapy's effects last over up to 14.5 y…
Sponsor: iECURE, Inc. • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
Could early lipid screening in High-Risk kids prevent future heart attacks?
Knowledge-focused Recruiting nowThis study screens children and adolescents aged 5 to 18 who have chronic conditions like congenital heart disease, inflammatory bowel disease, celiac disease, or rheumatic diseases for lipid metabolism disorders. Participants provide a blood sample and complete a questionnaire a…
Sponsor: Alexandra Miriam Kiess • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
Do patients take their meds? new study aims to find out
Knowledge-focused Recruiting nowThis study at Necker Hospital in Paris is checking how well patients with inherited metabolic diseases follow their daily oral medication routines. About 200 patients (children aged 7 and up, teens, and adults) will fill out a questionnaire during a regular visit. The goal is to …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC
-
New registry aims to unlock secrets of rare childhood diseases
Knowledge-focused Recruiting nowThis study collects information from up to 250 patients with lysosomal storage diseases (like certain forms of MPS, Pompe, Gaucher, and Wolman disease) to understand how these conditions develop and respond to treatments given before birth. Researchers will track symptoms, lab re…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New registry aims to unlock secrets of rare diseases
Knowledge-focused Recruiting nowThis study is creating a large database to collect information on people with rare diseases like amyloidosis, sarcoidosis, and Gaucher disease. Researchers will track patients' health over time, including their symptoms, treatments, and outcomes. The goal is to improve diagnosis …
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Do special diets cause eating disorders in kids? new study investigates
Knowledge-focused Recruiting nowThis study looks at how often young children (ages 1 to 6) with inherited metabolic diseases develop eating disorders when they are on special diets. Researchers will use a feeding scale to measure eating problems in 200 children. The goal is to understand the link between these …
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC